Form 4: Jonathan Lim, Director at Boundless Bio, Acquires Stock Options
SEC Form 4 Filing
Director Jonathan Lim acquired 13,219 stock options in Boundless Bio, Inc. on March 27, 2024, vesting monthly starting April 27, 2024.
Summary
- Jonathan Lim, a director of Boundless Bio, Inc., filed a Form 4 on March 29, 2024.
- The filing reports a transaction that occurred on March 27, 2024, where Lim acquired 13,219 stock options.
- These options vest in 36 substantially equal monthly installments beginning on April 27, 2024.
- The expiration date for these options is March 26, 2034.
- The exercise price of the stock options is $16.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock option grants. The director's acquisition could be interpreted as a positive signal, but it's not definitively bullish.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of transaction: Jonathan Lim acquired stock options. |
| 04/27/2024 | Vesting start date for the stock options. |
| 03/26/2034 | Expiration date of the stock options. |
| 03/29/2024 | Date the Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.